Cargando…
[Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway
Autores principales: | Huang, Guihong, Tang, Bo, Tang, Kun, Dong, Xiaomin, Deng, Jungang, Liao, Luqin, Liao, Zengzhen, Yang, Hua, He, Songqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018447/ https://www.ncbi.nlm.nih.gov/pubmed/36866771 http://dx.doi.org/10.3892/or.2023.8510 |
Ejemplares similares
-
[Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway
por: Chen, Quan, et al.
Publicado: (2023) -
Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo
por: Tang, Bo, et al.
Publicado: (2023) -
[Retracted] PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway
por: Tang, Bo, et al.
Publicado: (2023) -
Retraction: Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
Publicado: (2022) -
A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction]
Publicado: (2022)